English

25 MAY
SÃO PAULO – SP - BRAZIL
(NOVOTEL MORUMBI)

PARTICIPANTS PROFILE

Product categories

Branded generics: 48.3%

Biological products: 43.3%

Biosimilars: 26.7%

Hospital products: 40.0%

Innovative medicines: 58.7%

more info




Partnering Strategy/Interests

In-licensing: 46.7%

Out-licensing: 40.0%

Co-marketing: 31.7%

Co-promotion: 26.7%

Co-development: 46.7%

more info




Therapeutic areas

Cardiovascular: 40.0%

CNS: 45.0%

Infectious diseases: 35.0%

Pain: 41.7%

Respiratory: 33.3%

more info



PARTICIPANTS 2016

In-licensing: 46.7%

Out-licensing: 40.0%

Co-marketing: 31.7%

Co-promotion: 26.7%

Co-development: 46.7%

Technology transfer: 25.0%

Outsourcing: 15.0%

Others: 18.3%

partner